Ventripoint Diagnostics VPTDF Stock
Ventripoint Diagnostics Price Chart
Ventripoint Diagnostics VPTDF Financial and Trading Overview
| Ventripoint Diagnostics stock price | 0.1 USD |
| Previous Close | 0.11 USD |
| Open | 0.11 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.1 - 0.12 USD |
| 52 Week Range | 0.09 - 0.27 USD |
| Volume | 12.2K USD |
| Avg. Volume | 35.87K USD |
| Market Cap | 18.51M USD |
| Beta (5Y Monthly) | 0.166426 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VPTDF Valuation Measures
| Enterprise Value | 13.2M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 389.93683 |
| Price/Book (mrq) | 5.3636365 |
| Enterprise Value/Revenue | 278.13 |
| Enterprise Value/EBITDA | -2.51 |
Trading Information
Ventripoint Diagnostics Stock Price History
| Beta (5Y Monthly) | 0.166426 |
| 52-Week Change | -42.38% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.27 USD |
| 52 Week Low | 0.09 USD |
| 50-Day Moving Average | 0.13 USD |
| 200-Day Moving Average | 0.19 USD |
VPTDF Share Statistics
| Avg. Volume (3 month) | 35.87K USD |
| Avg. Daily Volume (10-Days) | 8.94K USD |
| Shares Outstanding | 156.82M |
| Float | 154.08M |
| Short Ratio | N/A |
| % Held by Insiders | 1.75% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -11100.71% |
| Gross Margin | 80.76% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.75% |
| Return on Equity (ttm) | -95.082% |
Income Statement
| Revenue (ttm) | 47.46K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -84.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5258423 USD |
| Net Income Avi to Common (ttm) | -5208929 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.28M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 459.3K USD |
| Total Debt/Equity (mrq) | 13.59 USD |
| Current Ratio (mrq) | 4.056 |
| Book Value Per Share (mrq) | 0.022 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4097675 USD |
| Levered Free Cash Flow (ttm) | -2422684 USD |
Profile of Ventripoint Diagnostics
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 18 Hook Avenue |
| ZIP | M6P 1T4 |
| Phone | 416-848-4156 |
| Website | https://www.ventripoint.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.
Q&A For Ventripoint Diagnostics Stock
What is a current VPTDF stock price?
Ventripoint Diagnostics VPTDF stock price today per share is 0.1 USD.
How to purchase Ventripoint Diagnostics stock?
You can buy VPTDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ventripoint Diagnostics?
The stock symbol or ticker of Ventripoint Diagnostics is VPTDF.
Which industry does the Ventripoint Diagnostics company belong to?
The Ventripoint Diagnostics industry is Medical Devices.
How many shares does Ventripoint Diagnostics have in circulation?
The max supply of Ventripoint Diagnostics shares is 167.34M.
What is Ventripoint Diagnostics Price to Earnings Ratio (PE Ratio)?
Ventripoint Diagnostics PE Ratio is now.
What was Ventripoint Diagnostics earnings per share over the trailing 12 months (TTM)?
Ventripoint Diagnostics EPS is -0.02 USD over the trailing 12 months.
Which sector does the Ventripoint Diagnostics company belong to?
The Ventripoint Diagnostics sector is Healthcare.